A Study of SHP655 (rADAMTS13) in Sickle Cell Disease
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Sickle Cell Disease
- Type
- Interventional
- Phase
- Phase 1Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 65 years
- Gender
- Both males and females
Description
This study will be conducted in 2 parts (part A and part B). Part A will include approximately 20 participants with baseline SCD and part B will include approximately 36 participants with SCD and acute VOC requiring hospitalization.
This study will be conducted in 2 parts (part A and part B). Part A will include approximately 20 participants with baseline SCD and part B will include approximately 36 participants with SCD and acute VOC requiring hospitalization.
Tracking Information
- NCT #
- NCT03997760
- Collaborators
- Takeda Development Center Americas, Inc.
- Investigators
- Study Director: Study Director Shire